Alcohol Weakens Cancer Immunotherapy In Study

Regular alcohol use can weaken a major form of cancer immunotherapy according to a new study in Science Signaling. The work focused on anti PD1 drugs that release the brakes on T cells so they can attack tumours. In mice with lung and bladder cancer moderate to heavy drinking cut immunotherapy success by half and raised the chance of tumours returning. A similar pattern appeared in patient records where people who drank more than one drink a week gained less survival benefit. Alcohol reduced the number of tumour fighting T cells entering tumours and lowered their ability to release key attack signals. It also raised levels of a second brake protein called TIGIT on T cells. When researchers blocked both PD1 and TIGIT together the treatment response in alcohol exposed mice recovered. The findings point to drinking history as a factor doctors may need to weigh in immunotherapy care.

image
advertisement
"We will never ask you to login, or register through a third-party advertisement."